Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $3.58 Million - $4.43 Million
-58,700 Reduced 99.49%
300 $18,000
Q1 2023

May 12, 2023

BUY
$70.23 - $86.01 $4.12 Million - $5.05 Million
58,700 Added 19566.67%
59,000 $4.26 Million
Q3 2022

Nov 14, 2022

SELL
$66.18 - $82.86 $1.97 Million - $2.46 Million
-29,700 Reduced 99.0%
300 $20,000
Q2 2022

Aug 12, 2022

BUY
$66.18 - $83.18 $1.99 Million - $2.5 Million
30,000 New
30,000 $0

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $14.6B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.